Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.30 |
| ▸ | CNR1 | P21554 | 1/20 | 0.30 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6661203 | 0.86 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL9592948 | 0.86 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL180016 | 0.83 | — | — | |
| SCHEMBL9720442 | 0.83 | GRIA1 (0.35) | ALDH1A1 | |
| SCHEMBL1484286 | 0.83 | — | — | |
| SCHEMBL23838528 | 0.83 | — | — | |
| SCHEMBL8457986 | 0.83 | GRIA1 (0.35) | ALDH1A1 | |
| SCHEMBL6722313 | 0.83 | GRIA1 (0.35) | ALDH1A1 | |
| SCHEMBL8736110 | 0.83 | LMNA (0.33) | TSHRLMNACNR1ADRA1ATDP1 | |
| SCHEMBL20762441 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12215177-B2 | Contaminant remediation with functionalized (meth)acrylic polymer or copolymer macroparticulates and systems related thereto | COUNTERTRACE LLC (US) | 2025-02-04 | — | — | US | claimed |
| US-20240117093-A1 | CONTAMINANT REMEDIATION WITH FUNCTIONALIZED (METH)ACRYLIC POLYMER OR COPOLYMER MACROPARTICULATES AND SYSTEMS RELATED THERETO | COUNTERTRACE LLC (US) | 2024-04-11 | — | — | US | claimed |
| US-20220259350-A1 | CONTAMINANT REMEDIATION WITH FUNCTIONALIZED (METH)ACRYLIC POLYMER OR COPOLYMER MACROPARTICULATES AND SYSTEMS RELATED THERETO | COUNTERTRACE LLC (US) | 2022-08-18 | — | — | US | claimed |
| US-20220259351-A1 | FUNCTIONALIZED (METH)ACRYLIC POLYMER OR COPOLYMER MACROPARTICULATES AND METHODS FOR PRODUCTION AND USE THEREOF | COUNTERTRACE LLC (US) | 2022-08-18 | — | — | US | claimed |
| EP-3997189-A1 | CONTAMINANT REMEDIATION WITH FUNCTIONALIZED (METH)ACRYLIC POLYMER OR COPOLYMER MACROPARTICULATES AND SYSTEMS RELATED THERETO | Countertrace LLC (US) | 2022-05-18 | — | — | EP | claimed |
| EP-3997136-A1 | FUNCTIONALIZED (METH)ACRYLIC POLYMER OR COPOLYMER MACROPARTICULATES AND METHODS FOR PRODUCTION AND USE THEREOF | Countertrace LLC (US) | 2022-05-18 | — | — | EP | claimed |
| WO-2021007441-A1 | CONTAMINANT REMEDIATION WITH FUNCTIONALIZED (METH)ACRYLIC POLYMER OR COPOLYMER MACROPARTICULATES AND SYSTEMS RELATED THERETO | COUNTERTRACE LLC (US) | 2021-01-14 | — | — | WO | claimed |
| WO-2021007432-A1 | FUNCTIONALIZED (METH)ACRYLIC POLYMER OR COPOLYMER MACROPARTICULATES AND METHODS FOR PRODUCTION AND USE THEREOF | COUNTERTRACE LLC (US) | 2021-01-14 | — | — | WO | claimed |
| US-20250115695-A1 | CONTAMINANT REMEDIATION WITH FUNCTIONALIZED (METH)ACRYLIC POLYMER OR COPOLYMER MACROPARTICULATES AND SYSTEMS RELATED THERETO | COUNTERTRACE LLC (US) | 2025-04-10 | — | — | US | disclosed |
| US-12215177-B2 | Contaminant remediation with functionalized (meth)acrylic polymer or copolymer macroparticulates and systems related thereto | COUNTERTRACE LLC (US) | 2025-02-04 | — | — | US | disclosed |
| US-12076340-B2 | Use of trientine to deliver copper to ischemic tissue | INNOLIFE CO., LTD. (CN) | 2024-09-03 | — | — | US | disclosed |
| US-20240117093-A1 | CONTAMINANT REMEDIATION WITH FUNCTIONALIZED (METH)ACRYLIC POLYMER OR COPOLYMER MACROPARTICULATES AND SYSTEMS RELATED THERETO | COUNTERTRACE LLC (US) | 2024-04-11 | — | — | US | disclosed |
| US-11795150-B2 | Synthesis of triethylenetetramines | PHILERA NEW ZEALAND LIMITED (NZ) | 2023-10-24 | — | — | US | disclosed |
| US-20220259351-A1 | FUNCTIONALIZED (METH)ACRYLIC POLYMER OR COPOLYMER MACROPARTICULATES AND METHODS FOR PRODUCTION AND USE THEREOF | COUNTERTRACE LLC (US) | 2022-08-18 | — | — | US | disclosed |
| US-20060041170-A1 | starting the reaction of alkylating ethylenediamine with formaldehyde to form pure triethylenetetramine; salt formation of triethylenetetramine disuccinate or triethylenetetramine tetrahydrochloride | PHILERA NEW ZEALAND LIMITED (NZ) | 2006-02-23 | — | — | US | disclosed |
| US-20030232799-A1 | Copper chelators for treating ocular Inflammation | LI, NING, DR. (CN) | 2003-12-18 | — | — | US | disclosed |
| EP-1370254-A2 | COPPER CHELATORS FOR TREATING OCULAR INFLAMMATION | The University of British Columbia (CA) | 2003-12-17 | — | — | EP | disclosed |
| US-20030055113-A1 | Copper chelators for treating ocular inflammation | UNIVERSITY OF BRITISH COLUMBIA, THE (CA) | 2003-03-20 | — | — | US | disclosed |
| WO-2002043722-A2 | COPPER CHELATORS FOR TREATING OCULAR INFLAMMATION | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2002-06-06 | — | — | WO | disclosed |
| US-5863879-A | POLYMER IS FORMED BY REACTING A POLYMER CONTAINING VINYLAMINE UNIT WITH COMPOUNDS CONTAINING ALDEHYDE OR KETO GROUPS AND OPTIONAL OTHER AMINE OR ALOCHOL CONTAINING COMPOUNDS SUCH AS AMINAL, HEMIAMINAL OR AMINAL ACETATE | BASF AKTIENGESELLSCHAFT (DE) | 1999-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11795150-B2 | Synthesis of triethylenetetramines | PNMT, TES, TPR | ALDH1A1 4075/4885TSHR 932/4885MAPK1 3313/4885 |
| US-12076340-B2 | Use of trientine to deliver copper to ischemic tissue | HIF1A, HIF1AN, P4HA1 | ALDH1A1 40/4885TSHR 1099/4885MAPK1 3257/4885 |
| US-20060041170-A1 | starting the reaction of alkylating ethylenediamine with formaldehyde to form pure triethylenetetramine; salt formation of triethylenetetramine disuccinate or triethylenetetramine tetrahydrochloride | TET1, TET2, TET3 | ALDH1A1 3779/4885TSHR 982/4885MAPK1 3022/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.